|
European Atherosclerosis Society 2019 meeting May 26-29
|
7
|
Resverlogix Corp.
|
May 20, 2019 12:18PM
|
|
Re: ... Looking Ahead...
|
7
|
Resverlogix Corp.
|
Feb 25, 2017 02:14PM
|
|
Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases 11/8/19
|
7
|
Resverlogix Corp.
|
Nov 23, 2019 10:33AM
|
|
Re: Q4 2019 Events
|
7
|
Resverlogix Corp.
|
Oct 07, 2019 04:22PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
7
|
Resverlogix Corp.
|
Mar 24, 2020 02:53PM
|
|
Re: Constellation Pharma
|
7
|
Resverlogix Corp.
|
Jun 30, 2020 09:29AM
|
|
Re: A healthy debate....
|
7
|
Resverlogix Corp.
|
Jun 03, 2019 01:13PM
|
|
Re: COVID 19 & BP
|
7
|
Resverlogix Corp.
|
Jun 27, 2020 10:48PM
|
|
Re: Just a thought - Should we really be expecting maximum exposure for BETonMACE results?
|
7
|
Resverlogix Corp.
|
Jul 02, 2019 09:56PM
|
|
5-point vs. 3-point MACE
|
7
|
Resverlogix Corp.
|
Oct 19, 2015 10:59AM
|
|
AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
7
|
Zenith Epigenetics
|
Feb 20, 2020 02:24PM
|
|
Re: Their finest hour
|
7
|
Resverlogix Corp.
|
Sep 24, 2019 01:58PM
|
|
Re: Piper's 17 biopharma surprises for 17
|
7
|
Resverlogix Corp.
|
Dec 22, 2016 10:35AM
|
|
Re: Just back from IR,...
|
7
|
Resverlogix Corp.
|
Oct 28, 2019 08:51PM
|
|
Re: AZ brand
|
7
|
Resverlogix Corp.
|
May 24, 2018 03:55PM
|
|
Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 09:57AM
|
|
The therapeutic potential of BRD4 in cardiovascular disease
|
7
|
Resverlogix Corp.
|
May 20, 2020 08:10AM
|
|
Re: Study Demonstrates Resverlogix’s Apabetalone Significantly Improves Cognition & Reduces Cognitive Decline Among Patients with Both CVD & Diabetes
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 10:00AM
|
|
Re: fully adjudicated?
|
7
|
Resverlogix Corp.
|
Apr 07, 2019 08:42PM
|
|
Re: Renal trial delayed (again)
|
7
|
Resverlogix Corp.
|
Sep 30, 2017 02:30PM
|
